18F-FDG-PET/CT在儿童肉瘤中的作用
本文综述18F-FDG-PET/CT在儿童肉瘤中的应用价值。该检查在分期中有明确作用,在骨转移识别方面文献一致提示其敏感性和特异性优于骨显像,但对肺转移识别及预后预测的价值尚不明确,骨肉瘤中SUVmax变化或可预测新辅助化疗后组织学反应及总体结局,尤文肉瘤和横纹肌肉瘤研究结论不一,非横纹肌肉瘤软组织肉瘤中的作用目前未知。
要点
- 18F-FDG-PET/CT在儿童肉瘤分期中有明确作用。
- 识别骨转移时文献一致提示其敏感性和特异性优于骨显像。
- 对预后预测的价值尚不明确,各组织学亚型研究结论不一。
核心结论
- 18F-FDG-PET/CT在儿童肉瘤分期中有明确作用,但在预后判断中的价值仍不明确。
- 在骨肉瘤、尤文肉瘤和横纹肌肉瘤中,识别骨转移时文献一致提示其敏感性和特异性优于骨显像。
- 识别肺转移的作用较不明确,儿童非横纹肌肉瘤软组织肉瘤中的作用目前未知。
- 骨肉瘤中SUVmax变化或可预测新辅助化疗后组织学反应及总体结局,尤文肉瘤和横纹肌肉瘤相关研究结论存在冲突。
- 需要更多前瞻性及更大规模研究以确定如何最佳地将18F-FDG-PET/CT纳入儿童肉瘤治疗方案。
研究设计与样本
- 综述,检索范围及纳入研究方法学信息原文未报告。
主要发现
- 在骨肉瘤、尤文肉瘤和横纹肌肉瘤中,识别骨转移时文献一致提示18F-FDG-PET/CT的敏感性和特异性优于骨显像。
- 识别肺转移的作用较不明确。
- 骨肉瘤中多项研究提示SUVmax变化可预测新辅助化疗后组织学反应及总体结局。
- 尤文肉瘤和横纹肌肉瘤中关于18F-FDG-PET/CT作为预后工具的研究结论存在冲突。
- 儿童非横纹肌肉瘤软组织肉瘤中18F-FDG-PET/CT的作用目前未知。
关键数值与推荐
- 原文未报告具体诊断阈值、SUVmax数值或推荐条款。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出大多数研究规模小且为回顾性研究。
- 原文指出需要更多前瞻性及更大规模研究以确定如何最佳地将18F-FDG-PET/CT纳入儿童肉瘤治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Considerable debate remains regarding how best to incorporate 18F-FDG-PET/CT into clinical practice for pediatric sarcomas. Although there is a clear role for 18F-FDG-PET/CT in staging pediatric sarcoma, the value of 18F-FDG-PET/CT in prognostication for pediatric sarcomas remains unclear. In osteosarcoma, Ewing sarcoma, and rhabdomyosarcoma, 18F-FDG-PET/CT may be most useful in the identification of skeletal metastases, where the literature consistently suggests that it has improved sensitivity and specificity as compared to bone scintigraphy. The role of the imaging modality in the identification of pulmonary metastatic disease is less clear. Further controversy exists regarding the use of 18F-FDG-PET/CT in predicting outcome. Several studies, particularly in osteosarcoma, suggest changes in the maximal standardized uptake value (SUVmax) that can predict histologic response following neoadjuvant chemotherapy as well as overall outcome. Conversely, studies are conflicting regarding the use of 18F-FDG-PET/CT as a prognostic tool in Ewing sarcoma and rhabdomyosarcoma. The role of 18F-FDG-PET/CT in pediatric nonrhabdomyosarcoma soft tissue sarcomas is unknown at this time. Although most studies have been small and retrospective, in certain histologic subtypes, there is a clear role for the use of this imaging modality. Additional prospective and larger studies are needed to fully determine how best to incorporate 18F-FDG-PET/CT into treatment regimens for pediatric sarcomas in the future.
引用
- Harrison DJ, Parisi MT, Shulkin BL, et al. The Role of 18F-FDG-PET/CT in Pediatric Sarcoma. Semin Nucl Med. 2017. PMID: 28417853. doi:10.1053/j.semnuclmed.2016.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。